𝔖 Bobbio Scriptorium

✦ LIBER ✦

Influence and Critique of the JUPITER Trial (Statins v No Statins for Primary Prevention of Cardiovascular Events in Patients with Normal Lipids and Elevated C-Reactive Protein)

✍ Scribed by Russell H. Samson; Deepak G. Nair

Book ID: 114475451
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 256 KB
Volume: 24
Category: Article
ISSN: 0895-7967
DOI: 10.1053/j.semvascsurg.2011.10.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Baseline Characteristics of Participants

Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein

✍ Paul M. Ridker; Francisco A.H. Fonseca; Jacques Genest; Antonio M. Gotto; John J 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Rosuvastatin in the Primary Prevention o

Rosuvastatin in the Primary Prevention of Cardiovascular Disease Among Patients With Low Levels of Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein: Rationale and Design of the JUPITER Trial*

✍ Ridker, P. M 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 427 KB

Prevalence of Low Low-Density Lipoprotei

Prevalence of Low Low-Density Lipoprotein Cholesterol With Elevated High Sensitivity C-Reactive Protein in the U.S.: Implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) Study

✍ Erin D. Michos; Roger S. Blumenthal 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Efficacy of Rosuvastatin Among Men and W

Efficacy of Rosuvastatin Among Men and Women With Moderate Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein: A Secondary Analysis From the JUPITER (Justification for the Use of Statins in Prevention–an Intervention Trial Evaluating Rosuvastatin) Trial

✍ Paul M. Ridker; Jean MacFadyen; Michael Cressman; Robert J. Glynn 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 502 KB

PCV72 COST-EFFECTIVENESS OF ROSUVASTATIN

PCV72 COST-EFFECTIVENESS OF ROSUVASTATIN FOR THE PRIMARY PREVENTION OF VASCULAR EVENTS ACCORDING TO FRAMINGHAM RISK SCORE IN PATIENTS WITH AN ELEVATED C-REACTIVE PROTEIN

✍ GP MacDonald 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB